Extreme, persistent pain can lead a person to make dramatic decisions, including getting rid of the painful body part. That's what Vincent Nasser, 28, of Squirrel Hill decided to do last summer.
Jun 24, 2014
1
0
(Medical Xpress)—Working with mice and human blood and liver samples, scientists from the Johns Hopkins Children's Center have identified a previously unsuspected liver hormone as a critical player in the development of ...
Apr 3, 2014
0
0
Researchers replicated human pancreatic beta cells—which produce insulin—in a mouse model in which donor cells were transplanted. The newly replicated cells retained features of mature beta cells and showed a physiological ...
Jan 16, 2014
0
0
Two new studies led by UC San Francisco (UCSF) scientists shed new light on the nature of beta cells, the insulin-producing cells in the pancreas that are compromised in diabetes.
Jan 14, 2014
0
0
The pancreas is a large organ that wraps around our gut, and produces the exact amount of insulin our bodies need when we eat – except when we start to develop diabetes, and insulin production slows down. Sydney scientists ...
Oct 29, 2013
0
0
(HealthDay)—Using a specially designed chamber, an international research team has transplanted islet cells into a patient with type 1 diabetes.
Oct 28, 2013
2
0
New technology has enabled scientists to prove that most people with type 1 diabetes have active beta cells, the specialised insulin-making cells found in the pancreas. Type 1 diabetes occurs when the body's immune system ...
Oct 9, 2013
0
0
The latest approach to islet transplantation, in which clusters of insulin-producing cells known as islets are transplanted from a donor pancreas into another person's liver, has produced substantially improved results for ...
Sep 19, 2013
0
0
The DiMelli (Diabetes Mellitus Incidence Cohort Registry) study examines the frequency and characteristics of diabetes phenotypes in children and young adults below the age of 20. The study was commissioned to investigate ...
Sep 12, 2013
0
0
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network (ITN), ...
Aug 27, 2013
0
0
